相关实验视频

Updated: May 5, 2026

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Published on: July 3, 2014

脑内出血后的抗血小板复苏:系统性审查和元分析

Sarah Yahya Alharthi¹, Sarah Abdulaziz Alsheikh¹, Dawood Salman Almousa¹

¹College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.

Diagnostics (Basel, Switzerland)

|July 29, 2025

概括

脑内出血后的早期抗血小板治疗显著降低了46%的复发出血. 这种关键的干预措施不会增加主要缺血或出血并发症的风险,提供了更安全的管理策略.

科学领域:

神经学神经学
心脏病学心脏病学
临床医学临床医学

背景情况:

脑内出血 (ICH) 的管理是具有挑战性的,因为抗血小板治疗和停药后缺血性中风的复发出血的双重风险.
由于缺乏基于证据的指导方针,医生在ICH后的早期抗血小板重启中表现出犹.

研究的目的:

通过元分析评估脑内出血后早期恢复抗血小板治疗的安全性和有效性.

主要方法:

在2025年4月之前对Web of Science,Scopus,PubMed和Cochrane图书馆进行系统审查.
包括10项研究 (8项观察性,2项RCT) 涉及5554名患有ICH的成年患者,生存时间超过24小时.
使用R软件进行统计分析,将分类结果以95%置信区间 (CI) 的风险比率 (RRs) 进行聚合.

主要成果:

早期的抗血小板治疗显著减少了46%的复发性ICH (RR0.54,95% CI 0.37-0.78,p=0.001).
在全因死亡率 (p=0.06),缺血性中风 (p=0.96),主要出血事件 (p=0.17) 或缺血性血管结果 (p=0.60) 中没有发现显著差异.

结论:

脑内出血后的早期抗血小板治疗与复发性出血事件显著减少46%有关.
早期恢复抗血小板治疗不会增加主要缺血或出血并发症的风险,支持其临床考虑.

关键词:

在这里,我找到了它.抗血小板药物可以预防血小板.脑内出血脑内出血一次性中风中风中风中风中风

更多相关视频

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Published on: October 15, 2021

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

相关概念视频

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Hemorrhagic Stroke l: Introduction

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...

Hemorrhagic Stroke ll: Pathophysiology

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...